Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized, Open-Label Study to Assess the Safety and Efficacy of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Elderly Patients Undergoing Colonoscopy Procedures

NCT00209599 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00209599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00209599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized, Open-Label Study to Assess the Safety and Efficacy of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Elderly Patients Undergoing Colonoscopy Procedures
Lead sponsor
Eisai Inc.
Phase
Phase 2
Overall status
Terminated
Start date
February 28, 2005
Completion date
March 31, 2005
Enrollment
100
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colon polyps, colonoscopy